Elia Seguí
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 13
- COVID-19 and healthcare impacts 5
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 4
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Javier Marco‐Hernández (3 shared papers)Aleix Prat (8 shared papers)Margarita Viladot (2 shared papers)Francesco Schettini (4 shared papers)Joan Padrosa (3 shared papers)Núria Chic (3 shared papers)Richard Buus (1 shared paper)Benedetta Conte (2 shared papers)
- Journals
- Annals of Oncology (5 papers)Journal of Clinical Oncology (3 papers)npj Breast Cancer (1 paper)Journal of Immunotherapy (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- SpainItalyUnited States
In The Last Decade
Elia Seguí
15 papers receiving 67 citations
Peers
Comparison fields: 5 of 25
- Cancer Research 22
- Oncology 33
- Pulmonary and Respiratory Medicine 17
- Immunology 8
- Rehabilitation 2
Countries citing papers authored by Elia Seguí
This map shows the geographic impact of Elia Seguí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elia Seguí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elia Seguí more than expected).
Fields of papers citing papers by Elia Seguí
This network shows the impact of papers produced by Elia Seguí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elia Seguí. The network helps show where Elia Seguí may publish in the future.
Co-authors
The 25 scholars most cited alongside Elia Seguí, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 14 | |
| 2 | 2021 | 10 | |
| 3 | 2022 | 9 | |
| 4 | 2023 | 8 | |
| 5 | 2021 | 4 | |
| 6 | 2024 | 4 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 3 | |
| 9 | 2020 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2025 | 1 | |
| 15 | [Postpartum hemolytic uremic syndrome: a rare entity and a treatment challenge]. | 2008 | 1 |
| 16 | 2022 | 0 | |
| 17 | 2021 | 0 | |
| 18 | 2020 | 0 | |
| 19 | 2020 | 0 |
About Elia Seguí
Elia Seguí is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Infectious Diseases, having authored 19 papers that have together received 67 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (5 papers), Breast Cancer Treatment Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Genomics and Diagnostics (2 papers), Estrogen and related hormone effects (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Cancer Research (22 citations), Oncology (33 citations), Pulmonary and Respiratory Medicine (17 citations), Immunology (8 citations) and Rehabilitation (2 citations). Elia Seguí has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include Javier Marco‐Hernández, Aleix Prat, Margarita Viladot, Francesco Schettini, Joan Padrosa, Núria Chic, Richard Buus, Benedetta Conte, Giovanni Scambia and Laia Paré. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, npj Breast Cancer, Journal of Immunotherapy and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.